Financhill
Back

ProShares Ultra Dow30 Vs. Nektar Therapeutics Industry Stock Comparison

Buy
76

DDM
ProShares Ultra Dow30

Last Price:
$57.95
Seasonality Move:
-0.31%
Sell
45

NKTR
Nektar Therapeutics

Last Price:
$44.43
Seasonality Move:
6.44%
Buy
76
ProShares Ultra Dow30 (DDM) is a Buy

Is ProShares Ultra Dow30 a Buy, Sell or Hold?

  • The current ProShares Ultra Dow30 [DDM] share price is $57.77. The Score for DDM is 76, which is 52% above its historic median score of 50, and infers lower risk than normal.
  • DDM is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
45
Nektar Therapeutics (NKTR) is a Sell

Is Nektar Therapeutics a Buy, Sell or Hold?

  • The current Nektar Therapeutics [NKTR] share price is $44.46. The Score for NKTR is 45, which is 10% below its historic median score of 50, and infers higher risk than normal.
  • NKTR is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

DDM Stock Price Chart

What is ProShares Ultra Dow30's stock price today?

  • The ProShares Ultra Dow30 share price today is $57.77
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DDM is experiencing slight buying pressure.

NKTR Stock Price Chart

What is Nektar Therapeutics's stock price today?

  • The Nektar Therapeutics share price today is $44.46
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NKTR is experiencing buying pressure, which is a positive indicator for future bullish movement.

DDM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.7 Buy
Relative Strength Index (14 RSI): 58.77 Buy
Chaikin Money Flow: 292043 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (53.92 - 57.7) Buy
Bollinger Bands (100): (51.13 - 56.09) Buy

NKTR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.56 Sell
Relative Strength Index (14 RSI): 37.11 Sell
Chaikin Money Flow: 657085 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (48.71 - 61.11) Sell
Bollinger Bands (100): (35.93 - 62.65) Sell

DDM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 57.57 Buy
20-day SMA: 56.58 Buy
50-day SMA: 55.39 Buy
200-day SMA: 49.53 Buy
8-day EMA: 57.26 Buy
20-day EMA: 56.64 Buy
50-day EMA: 55.44 Buy
200-day EMA: 51.39 Buy

NKTR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.67 Sell
20-day SMA: 54.26 Sell
50-day SMA: 56.89 Sell
200-day SMA: 31.84 Buy
8-day EMA: 47.39 Sell
20-day EMA: 51.76 Sell
50-day EMA: 53.5 Sell
200-day EMA: 38.45 Buy

ProShares Ultra Dow30 Earnings Growth & DDM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Nektar Therapeutics Earnings Growth & NKTR Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.41 per share, a decrease next quarter of $0.00 per share, an increase this year of $3.68 per share, and a decrease next year of $3.54 per share.

ProShares Ultra Dow30 Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nektar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):